SI
SI
discoversearch

Strategies & Market Trends : Low Price/Cash Ratio Value Stocks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: stock leader who wrote (1721)10/5/2017 10:34:40 PM
From: Elroy  Read Replies (1) of 1753
 
Hmmm, maybe so.

I find it hard to understand why investors would prefer drugs used to treat rare diseases instead of drugs used to treat very common diseases.......

I recall the conference call following the announcement, and the Rocket guys described some of the diseases they were trying to treat. He said stuff like "About 1,000 people per year contract this disease....."

How you going to justify a $500 million market cap curing 1,000 people per year?

Anyway, I'm out of ITEK, but I still have all my GRV.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.